Invitation To Enefit Green Investor Webinars Presenting Q3 2024 Interim Results

( MENAFN - GlobeNewsWire - Nasdaq) Enefit Green will publish its Q3 2024 interim report on 31 October 2024 at 09.00 EET and will host two online webinars to present the results according to the following schedule. 31 October 2024 at 11.

00 EET webinar in Estonian 31 October 2024 at 13.00 EET webinar in English To join the event, please click here (same LINK for both languages). During both events results will be presented by Juhan Aguraiuja, CEO, Andres Maasing, CDO and Sven Kunsing, Head of Finance Communication.



Each session will be followed by Q & A. As the duration of the events will be limited to approximately 1 hour, we encourage participants to send their questions beforehand to ..

. . The recording of the webinars will be made available on the company's web page.

Further information: Sven Kunsing Head of Finance Communication ...

Enefit Green is one of the leading renewable energy producers in the Baltic Sea area. The Company operates wind farms in Estonia and Lithuania, waste-to-energy CHP plant in Estonia, solar farms in Estonia and Poland and a hydroelectric plant in Estonia. In addition, the Company is developing several wind and solar farms in the mentioned countries, Latvia and Finland.

As of the end of 2023, the Company had a total installed electricity production capacity of 515 MW and a total installed heat production capacity of 50 MW. During 2023, the Company produced 1,343 GWh of electricity, 604 GWh of heat energy and 156 thousand tonnes of wood pellets. In the end of 2023, Enefit Green exited the biomass based CHP and pellet production businesses.

MENAFN28102024004107003653ID1108823375 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

.